All News

Industry Insights

bluebird bio Receives Second FDA Approval for a Gene Therapy in Two Months with Skysona for CALD
20 September 2022
bluebird bio Receives Second FDA Approval for a Gene Therapy in Two Months with Skysona for CALD
bluebird bio’s Skysona has become
Capstan Therapeutics – Spin-Out from Penn University Launches with $165 Million to Deliver in vivo CAR-T
20 September 2022
Capstan Therapeutics – Spin-Out from Penn University Launches with $165 Million to Deliver in vivo CAR-T
Biotechnology company Capstan Therapeutics has
Phacilitate’s ATE Round-Up: People, Patients, and Possibilities
12 September 2022
Phacilitate’s ATE Round-Up: People, Patients, and Possibilities
In this blog we take
Phacilitate’s ATE Plenary: Celebrating Science and Stripes
2 September 2022
Phacilitate’s ATE Plenary: Celebrating Science and Stripes
In this blog, we round-up
POPULAR NEWS ITEMS
Image
4 October 2022

AmplifyBio Acquires PACT Pharma to Advance Cell and Gene Therapy Services

Image
3 October 2022

Janssen Presents Positive Data from Two Ophthalmological Gene Therapy Programs

Image
22 September 2022

CAR-T Manufacturing Challenges and How to Overcome Them

New Technologies for Cell Therapy Manufacturing with Invetech
26 August 2022
New Technologies for Cell Therapy Manufacturing with Invetech
David Hodl, Head of Business
Scale-Up Technology for AAV Production
24 August 2022
Scale-Up Technology for AAV Production
When scaling up production of
Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals
10 August 2022
Stevenage Bioscience Hub’s Lab Hotel Joined by Inspira Pharmaceuticals
World-leading life science park Stevenage
5 Top Takeaways from ASGCT’S Q2 2022 Quarterly Data Report
25 July 2022
5 Top Takeaways from ASGCT’S Q2 2022 Quarterly Data Report
Phacilitate’s Ryan Leahy summarizes his
Load more News
RECOMENDED TOPICS
Industry Insights
Manufacturing
Techniques
Uncategorized
POPULAR NEWS ITEMS
Image

AmplifyBio Acquires PACT Pharma to Advance Cell and Gene Therapy Services

Image

Janssen Presents Positive Data from Two Ophthalmological Gene Therapy Programs

Image

CAR-T Manufacturing Challenges and How to Overcome Them